A new study has discovered a highly promising therapy for patients with cognitive and behavioral variant frontotemporal dementia, the second most common type of dementia in people under the age of 60, resulting in the stabilization of what would otherwise be escalating behavioral issues and the slowing of disease-related brain shrinkage